Praxis Precision Medicines (PRAX) Stocklytics Forecast

Praxis Precision Medicines Inc (PRAX) is a biopharmaceutical company focused on developing precision therapies for patients with central nervous system disorders. The company's mission is to transform the lives of patients by targeting the underlying genetic drivers of their diseases. With a strong pipeline of innovative therapies, Praxis Precision Medicines is well-positioned for future growth and success.

The stock price of Praxis Precision Medicines Inc (PRAX) is subject to various factors that can influence its performance. Analysts have provided price targets for the company, with an average target of $75 by 2023. This indicates potential upside for investors who believe in the company's growth prospects. It is important to note that these price targets are based on analysts' assessments and can be subject to change based on market conditions and company developments.